Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with ovarian cancer
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To compare the effectiveness and safety of weekly paclitaxel with that of three‐weekly paclitaxel, in combination with carboplatin, as first‐line chemotherapy treatment for ovarian cancer.